7/1010 sources · 8 publishersUpdated Oct 9, 01:19 UTC
Humana shares jump after CMS upgrades key Medicare Advantage plan to 4‑star rating
On October 8, 2026 the Centers for Medicare & Medicaid Services raised Humana's H5216 Medicare Advantage plan from 3.5 to 4 stars for the 2027 rating cycle. The upgrade covers about 2.4 million members and restores the plan’s eligibility for federal bonus payments. Humana’s stock surged 12‑13% in after‑hours trading, while rival Alignment Healthcare fell sharply.
Why it matters
The higher rating re‑qualifies the plan for bonus payments, which can improve Humana’s profit margins and cash flow, as noted by the reporting outlets. Analysts upgraded the stock, citing earnings‑growth potential from the rating change.
Key facts
- 1CMS upgraded Humana's H5216 plan to a 4‑star rating for 2027, up from 3.5 stars. seekingalpha.com
- 2The plan covers roughly 2.4 million members. seekingalpha.com
- 3Humana shares rose about 13% in after‑hours trading on October 8, 2026. gurufocus.com
- 4Alignment Healthcare shares fell more than 20% after its rating dropped. finance.yahoo.com
- 5Humana reported quarterly revenue of $40.9 billion and net income of $694 million. timothysykes.com
- 6Barclays and Cantor Fitzgerald upgraded Humana to Overweight, setting price targets of $515 and $460 respectively. timothysykes.com
Summary written by AlphAI from 10 of 10 sources. Not investment advice. Figures are as stated by the linked sources.